Skip to content

13F-HR filed by Financial Perspectives, Inc

Financial Perspectives, Inc filed this 13F-HR for the quarter ended 2019-12-31, filed 2024-01-10, with 514 holding rows worth $146,522,359.

Accession
0002003287-24-000001
Filed
2024-01-10
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2019

A holdings report, 514 entries on the cover page, a total value of $146,522,359 stated on the cover page (in dollars after the unit check, H1), rows summing to $146,522,359 with VALUE read as dollars as filed, 13F file number 028-23491. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
DXC TECHNOLOGY CO COM23355L106Stock8$301dollars as filed
ADVANSIX INC00773T101COM15$299dollars as filed
ALCOA CORP COM013872106Stock11$237dollars as filed
SMUCKER J M CO832696405COM NEW2$208dollars as filed
BRIGHTHOUSE FINL INC10922N103COM5$196dollars as filed
RESIDEO TECHNOLOGIES INC COM76118Y104Stock16$191dollars as filed
PERSPECTA INC715347100COM4$106dollars as filed
GARRETT MOTION INC366505105COM10$100dollars as filed
NAVIOS MARITIME HOLDINGS INCY62197119COM20$90dollars as filed
AMERICAN INTL GROUP INC026874156*W EXP 01/19/2028$82dollars as filed
LENNAR CORP CL B526057302Stock1$45dollars as filed
FRONTIER COMMUNICATIONS CORP35906A306COM NEW8$7dollars as filed
PLUS THERAPEUTICS INC72941H400COM1$2dollars as filed
ANAPTYSBIO INC032724106COM0$0dollars as filedValue filed as zero, left out of ratios.Amount filed as zero, left out of ratios.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0002003287-24-000001this filing2024-01-10acceptance time not in the bulk data set